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Abstract
Background: Rho family GTPases are critical regulators of the cytoskeleton and affect cell migration, cell-cell adhesion, and
cell-matrix adhesion. As with all GTPases, their activity is determined by their guanine nucleotide-bound state.
Understanding how Rho proteins are activated and inactivated has largely focused on regulatory proteins such as guanine
nucleotide exchange factors (GEFs) and GTPase activating proteins (GAPs). However, recent in vitro studies have indicated
that GTPases may also be directly regulated by redox agents. We hypothesized that this redox-based mechanism occurs in
cells and affects cytoskeletal dynamics, and in this report we conclude this is indeed a novel mechanism of regulating the
GTPase RhoA.
Methodology/Principal Findings: In this report, we show that RhoA can be directly activated by reactive oxygen species
(ROS) in cells, and that this requires two critical cysteine residues located in a unique redox-sensitive motif within the
phosphoryl binding loop. First, we show that ROS can reversibly activate RhoA and induce stress fiber formation, a well
characterized readout of RhoA activity. To determine the role of cysteine residues in this mechanism of regulation, we
generated cysteine to alanine RhoA mutants. Mutation of these cysteines abolishes ROS-mediated activation and stress fiber
formation, indicating that these residues are critical for redox-regulation of RhoA. Importantly, these mutants maintain the
ability to be activated by GEFs.
Conclusions/Significance: Our findings identify a novel mechanism for the regulation of RhoA in cells by ROS, which is
independent of classical regulatory proteins. This mechanism of regulation may be particularly relevant in pathological
conditions where ROS are generated and the cellular redox-balance altered, such as in asthma and ischemia-reperfusion
injury.
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Introduction
Rho family GTPases serve as critical regulators of cell
migration, cell-cell adhesion, and cell-matrix adhesion, by
transmitting extracellular and intracellular signals to effectors that
act on the cytoskeleton. The best characterized members of the
Rho family of GTPases are RhoA, Rac1, and Cdc42; each of
which is associated with unique phenotypes and functions [1,2,3].
As with all canonical GTPases, the activity of Rho GTPases is
determined by their guanine nucleotide-bound state. Rho
GTPases are activated by binding GTP, which causes a
conformational change in the protein that greatly increases the
affinity for downstream effector proteins. These effector proteins
are components of signaling cascades which ultimately lead to
modulation of cellular functions. Conversely, GDP-bound Rho
GTPases are unable to bind effector proteins and are therefore
inactive. The switching between ‘‘on’’ and ‘‘off’’ states is tightly
controlled by regulatory proteins which interact with GTPases to
regulate guanine nucleotide binding [4]. Guanine nucleotide
exchange factors (GEFs) activate GTPases by promoting the
dissociation of GDP to allow the binding of GTP, which is
available in great excess over GDP levels in the cytoplasm.
GTPase activating proteins (GAPs) promote the hydrolysis of GTP
to GDP, preventing GTPase interaction with downstream
effectors. GDP-dissociation inhibitors (GDIs) maintain the inactive
state of the GTPase by preventing GDP-dissociation and
membrane association [5]. All of these regulatory proteins are
themselves affected by diverse upstream signals which serve to
activate or inactivate Rho GTPase signaling pathways.
Yet another mechanism for regulating GTPase activity has been
proposed that involves the action of redox agents, specifically
reactive oxygen species (ROS) and reactive nitrogen species
(RNS). ROS and RNS have been historically considered
pathological agents which can react with and damage many
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biological macromolecules including DNA, proteins and lipids.
However, there has been an increasing recognition that ROS and
RNS can also function in cell signaling pathways [6,7] in
particular, those pathways involving phosphatases [8]. Most cell
types produce ROS, either as byproducts of normal metabolism or
by specific enzyme complexes. A major source of ROS in cells is
the NADPH oxidase complex, which can be activated by Rac1
[9,10,11]. This generation of ROS by Rac1 has been implicated in
the redox-mediated regulation of RhoA activity. Nimnual et al.
described a novel mechanism in which downregulation of RhoA
occurs via redox-mediated inactivation of the phosphatase LMW-
PTP and subsequent elevation of p190 RhoGAP activity [12].
As well as affecting regulatory protein function, another body of
work shows that at least in vitro, oxidizing agents can also directly
regulate the activity of certain GTPases. Lander et al. were the first
to show this with Ras; NO treatment of recombinant Ras
increased the proportion of GTP-bound Ras and endogenous NO
activated Ras in human T cells [13,14]. Campbell’s group went on
to describe a radical-based mechanism for the stimulation of
nucleotide exchange on Ras by NO [15]. Interestingly, Campbell’s
group also identified a distinct redox-active motif located in the
phosphoryl-binding loop in another subset of GTPases, the Rho
family (RhoA, Rac1, and Cdc42) [16]. They found that treatment
of purified recombinant GTPase with superoxide anion radical or
nitrogen dioxide radicals in vitro resulted in guanine nucleotide
dissociation. The proposed mechanism involves electron transfer
of a thiol radical intermediate to the guanine base, which disrupts
interactions between the guanine nucleotide and the GTPase,
resulting in guanine nucleotide dissociation. In the presence of
radical quenching agents, the intermediates are reversed and
guanine nucleotide association can occur. Under conditions where
GTP is in excess, such as in the cell, the end result is exchange of
GDP for GTP, thereby activating the GTPase. Based on these in
vitro findings, we hypothesize that ROS can directly affect GTPase
activity in cells by oxidative modification of the critical cysteine
residues within the redox-active motif. This may be a novel
mechanism of regulating GTPase signaling cascades, independent
but parallel to classical regulation by GEFs and GAPs.
In this paper, we show that RhoA can be directly activated by
ROS in cells and that ROS-mediated activation of RhoA can
induce cytoskeletal rearrangement. By using cysteine to alanine
mutants, we demonstrate that ROS-mediated activation of RhoA
is dependent on cysteines 16 and 20. Our findings indicate that
ROS-mediated RhoA activation is another potential regulatory
mechanism in cells that can affect cytoskeletal dynamics.
Results
ROS Induces Reversible Activation of RhoA
Peroxides are short-lived, membrane permeable oxidants that
are generated in vivo by enzymatic complexes and as byproducts of
cellular metabolism. To determine if exogenous ROS affects the
activity of cellular RhoA, we treated REF-52 fibroblasts with low
doses (0.1 mM to 10 mM) of a stable analog of hydrogen peroxide,
t-butyl hydroperoxide (peroxide), for 10 min under serum-free
conditions. The doses of exogenous peroxide used are physiolog-
ically relevant, based on measurements of intracellular ROS
production made by others [6,17]. Using standard Rhotekin-RBD
pulldown assays, we observed that RhoA was significantly
activated by peroxide treatment, as shown in Figure 1A and the
accompanying quantification. To determine whether this activa-
tion is reversible, we treated REF-52 fibroblasts with 0.1 mM
peroxide for 10 min, followed by washout with media only
(Figure 1B). 0.1 mM peroxide activates endogenous RhoA, but the
activity returns to baseline levels within 15–30 min upon washout.
This reversibility suggests that the reducing environment of the
cytoplasm and presence of intracellular anti-oxidants rapidly
quench the effects of a bolus dose of exogenous peroxide. To
determine whether endogenous ROS can activate RhoA, we used
antimycin A, a compound that inhibits electron transport at
complex III of the mitrochondrial respiratory chain, thereby
inducing the production of superoxide and other ROS [18,19, and
Figure S1]. Treatment of cells with antimycin A resulted in
activation of RhoA (Figure 1C). This activation was prevented by
the presence of N-acetyl cysteine (NAC), a free radical and ROS
scavenger. Having confirmed that endogenous ROS exerts the
same effect on RhoA as extracellular peroxide, for all remaining
experiments we use peroxide instead of antimycin A. We also
examined whether peroxide would activate Rac1 in cells. With
REF-52 fibroblasts, low levels of activation were detected in some
experiments, but this was variable. However, with both HeLa cells
(Figure S2) and endothelial cells (data not shown), we routinely
observed robust activation of Rac1 in response to exogenous
peroxide at 0.1 mM to 10 mM concentrations.
ROS Treatment Induces Stress Fiber Formation
To further explore what functional consequences this ROS-
mediated RhoA activation might have in a cellular context, we
looked at stress fiber formation as it is a well-characterized
cellular readout of Rho activity [2]. For these experiments, Rat2
cells were used because upon serum-starvation they readily lose
stress fibers, allowing a low baseline from which induction of
stress fibers could be induced and more readily quantified. Rat2
cells were serum-starved for 1 h to cause loss of stress fibers, and
then treated with either 5% FBS as a positive control, or 1 mM
peroxide for 15 min. Cells were fixed and F-actin was detected
with Texas-Red labeled phalloidin. As expected, serum starvation
results in significant loss of actin stress fibers in Rat2 fibroblasts
(Figure 2A). Importantly, peroxide treatment induced formation
of prominent stress fibers to a similar extent as adding back serum
(Figure 2A). Stress fiber induction was quantified by scoring cells
for the presence of stress fibers and is represented as an index of
stress fiber induction in Figure 2B. The induction of stress fibers
by peroxide and FBS correlated with activation of RhoA in Rat2
cells (Figure 2C). To further show the role of RhoA in the
induction of stress fibers by peroxide and FBS, we used the Rho
kinase inhibitor Y27632. Y27632 inhibits Rho kinase and
therefore Rho-mediated contractility, preventing the formation
of stress fibers [20]. Pre-treatment with Y27632 significantly
reduced the percent of cells with prominent stress fibers after
peroxide or FBS treatment (Figure 2D). The ability of ROS to
induce cytoskeletal alterations has been described previously,
particularly in the context of oxidant-mediated changes in
endothelial cell permeability. These studies used both exogenous
hydrogen peroxide [21,22,23], or superoxide and related
molecules produced via the xanthine oxidase system [24]. It is
important to note that these studies used peroxide concentrations
in the range of 100–250 mM, and/or treatment for much longer
time (1–6 hours) than we have utilized here (1 mM for 15 min). In
addition to the formation of stress fibers, ROS treatment caused
monolayer gap formation and increased permeability in these
studies [22,24], which is also indicative of elevated RhoA activity
and increased actomyosin contractility induced via the Rho/Rho
kinase signaling pathway. Consistent with these earlier reports,
the data in Figure 1 and Figure 2 reveal that low concentrations
of ROS activate RhoA and promote stress fiber formation in
fibroblasts.
RhoA Activation by ROS
PLoS ONE | www.plosone.org 2 November 2009 | Volume 4 | Issue 11 | e8045
Redox-Sensitive Cysteine Residues Are Required for ROS-
Mediated Activation of RhoA
What is the mechanism for this redox regulation of RhoA?
Previously published in vitro observations have shown that RhoA
has a redox-sensitive motif (GXXXCGK(S/T)C) containing two
cysteine residues in the phosphoryl binding loop [16,25]. As shown
in Figure 3A, these cysteine residues are conserved in human,
mouse, and rat RhoA. Previous in vitro studies revealed that
oxidation of these cysteine residues, particularly cysteine 20,
resulted in displacement of the bound nucleotide. Subsequent
reduction allowed nucleotide to rebind, i.e. for nucleotide
exchange to occur [16,25]. To test whether these residues might
play a role in the regulation of RhoA activity in cells by ROS, we
mutated both cysteine 16 and 20 to alanine residues, thus making
them resistant to oxidative modification. To prevent interference
of endogenous RhoA in our experiments, we designed an
adenovirally delivered miRNA construct targeted against a
conserved region of RhoA, as shown in Figure 3B. Myc-tagged,
non-targeted wildtype (wt) and CRA (C16/20A) mutants were
designed with 5 silent mutations within the miRNA targeting
sequence, thus allowing re-expression of the myc-tagged wt and
C16/20A mutant proteins. Figure 3C demonstrates effective
knockdown of endogenous RhoA and simultaneous re-expression
of either wt or C16/20A myc-RhoA. Importantly, these myc-
tagged, non-targeted RhoA constructs retain the ability to bind
GTP as shown by GST-RBD pulldown assays in Figure 3D.
To test whether cysteine 16 and 20 are required for the redox-
sensitivity of RhoA, we examined the ability of C16/20A myc-
RhoA to be activated by ROS in cells. REF52 cells expressing wt
or C16/20A myc-RhoA were treated with various doses of
peroxide under serum-free conditions, followed by RBD pulldown
assay to detect RhoA activity. As shown in Figure 4A and the
accompanying quantification (Figure 4B), while wt myc-RhoA
responds to peroxide similarly to endogenous RhoA with
activation over baseline levels, the C16/20A myc-RhoA mutant
is resistant to activation by ROS. Importantly, data shown in
Figure 1. RhoA is reversibly activated upon exposure to ROS. (A) REF-52 fibroblasts were serum-starved followed by treatment with the
indicated concentrations of t-butyl hydroperoxide (peroxide) in serum-free DMEM for 10 min. RhoA activity assays show that peroxide treatment
results in the activation of endogenous RhoA. A representative blot of active RhoA sedimented by GST-RBD versus total RhoA from whole cell lysates
is shown. ImageJ software was used to quantify RhoA activation. Relative RhoA activity is the ratio of active RhoA divided by total RhoA normalized to
the untreated control. Graph represents the average +/2 SEM of 5 independent experiments. * p,0.05. (B) REF-52 fibroblasts were serum-starved
and treated as above with 100 nM peroxide for 10 min. Following peroxide treatment, the medium was either left unchanged (09) or replaced with
serum-free DMEM for 15 or 30 min (159, 309). The RhoA activity assay shows that peroxide-induced RhoA activation is reversible after washout. (C)
REF-52 fibroblasts were serum-starved with or without 0.5 mM NAC followed by treatment with 10 mM antimycin A (AA) for 30 min. RhoA activity
assays show that treatment with antimycin A results in the activation of endogenous RhoA. However, this activation is inhibited in cells pre-treated
with NAC. Representative blots of active RhoA sedimented by GST-RBD versus total RhoA from whole cell lysates are shown. ImageJ software was
used to quantify RhoA activation. Relative RhoA activity is the ratio of active RhoA divided by total RhoA normalized to the untreated control. Graph
represents the average +/2 SD of 3 independent experiments. * p,0.05, not signficiant (NS).
doi:10.1371/journal.pone.0008045.g001
RhoA Activation by ROS
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Figure 4 indicate that while the C16/20A RhoA mutant is
unresponsive to ROS treatment, it is still capable of being
activated and inactivated by other physiological stimuli. Thrombin
treatment is a well-characterized stimulus that induces RhoA
activation in a wide variety of cell types [26,27], an effect that is
mediated through the action of p115 RhoGEF, among others
[28,29,30]. Figure 4C shows that thrombin treatment activates wt
RhoA as expected, and also rapidly activates C16/20A myc-
RhoA, indicating that the mutant retains the ability to be activated
by GEFs. Conversely, we tested the ability of C3 toxin to
inactivate C16/20A myc-RhoA. C3 inactivates RhoA by ADP-
ribosylation, and treatment of cells with this toxin results in a
Figure 2. ROS treatment induces stress fiber formation. (A) Rat2 fibroblasts were grown on fibronectin-coated coverslips and either untreated,
serum-starved for 1 h, or serum-starved followed by 15 min treatment with 5% FBS or 1 mM peroxide. F-actin staining was detected with Texas-Red
labeled phalloidin. Serum-starvation results in loss of actin stress fibers; treatment with either FBS or peroxide induces prominent stress fibers. (B)
Cells treated as above were scored for the presence of stress fibers and graphed as an index of stress fiber induction (normalized to serum-starved).
Both FBS and peroxide result in an equally significant induction of stress fibers. Graph represents the mean of 3 independent experiments6SD, with
.300 cells counted for each condition. Actual percent cells with stress fibers for each condition is 75.367.5% (untreated), 42.3 6 4.6% (starved),
64.366.1% (serum-starved and peroxide treated), and 7366.4% (serum-starved and FBS treated). * p,0.05. (C) Rat2 fibroblasts were serum-starved
for 1 hr, followed by treatment with either 1 mM peroxide or 5% FBS for 15 min. RhoA activity assays show that both peroxide and FBS activate RhoA.
A representative blot of active RhoA sedimented by GST-RBD versus total RhoA from whole cell lysates is shown. ImageJ software was used to
quantify RhoA activation. Relative RhoA activity is the ratio of active RhoA divided by total RhoA normalized to the untreated control. Graph
represents the average +/2 SD of 2 independent experiments. * p,0.05. (D) Rat2 cells were grown as in panel A, serum-starved for 1 hr 65 mM
Y27632, and then treated for 15 min with 1 mM peroxide or 5% FBS. F-actin staining was detected with Texas-Red labeled phalloidin. Pre-treatment
with Y27632 significantly reduces the percent of cells with prominent stress fibers after both peroxide and FBS treatment. Graph represents the mean
of 3 independent experiments 6 SD with .300 cells counted for each condition.
doi:10.1371/journal.pone.0008045.g002
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characteristic dendritic phenotype [31,32]. REF52 cells expressing
either wt or C16/20A myc-RhoA respond to C3 as indicated by
this altered morphology (Figure 4D). Together, the results shown
in Figure 4 indicate that the cysteine to alanine mutations confer
resistance to ROS-mediated GTPase activation, but notably, still
maintain responsiveness of the GTPase to other physiological
stimuli.
ROS-Mediated Stress Fiber Induction Requires Redox-
Regulation of RhoA
We went on to test how the CRA mutations affect the cellular
function of RhoA by measuring peroxide-induced stress fiber
induction in Rat2 cells as in Figure 2, but with cells re-expressing
either wt or C16/20A myc-RhoA after knockdown of the
endogenous protein. As shown in Figure 5, both wt and C16/
20A myc-RhoA expressing cells have an equivalent amount of
stress fibers in an unstarved state, and both lose stress fibers to a
similar degree upon serum-starvation. However, while addition of
1 mM peroxide for 15 min induces stress fiber formation in cells
re-expressing wt myc-RhoA cells expressing C16/20A myc-RhoA
do not show any significant induction of stress fibers. These results
confirm that cysteine 16 and/or 20 are specifically required for
ROS-induced stress fiber formation by RhoA.
Discussion
ROS and RNS have been implicated in a variety of cell signaling
pathways, including growth factor signaling [6,7], inflammation
[33], engagement of integrins [34,35], and adhesion to extracellular
matrix (reviewed in [36]). Hydrogen peroxide in particular has
gained considerable attention as a potent signaling molecule [37].
Hydrogen peroxide and other ROS have been shown to be
generated both intracellularly and extracellularly. Extracellular
ROS generated by neutrophils can act on endothelial cells to affect
vascular permeability [38] and EGF receptor engagement has been
shown to induce the production of extracellular peroxide which can
then permeate the cell membrane to affect intracellular signaling
[39,40]. Most recently, the role of paracrine signaling by externally-
produced peroxide has been shown in a zebrafish wound healing
model. Niethammer et al. show that injured epithelial cells secrete
peroxide (in the range of 0.5 to 50 uM) to induce leukocyte
recruitment to the wound [41].
Figure 3. Characterization of RhoA miRNA and re-expression of non-targetable (NT) redox-resistant RhoA mutant constructs. (A)
RhoA protein sequence (amino acids 1–25) showing conserved putative redox-sensitive cysteines C16 and C20 (shaded residues). (B) Nucleotide
sequence (bp 43–87) of rat, mouse, and human RhoA showing the region targeted by the RhoA miRNA used in this study (shaded area). To re-express
non-targeted RhoA constructs five silent mutations were introduced in the miRNA targeting region (black boxes). Nucleotides corresponding to C16
and C20 are underlined. (C) Knockdown of endogenous RhoA and simultaneous re-expression of non-targeted (NT) mutant constructs. REF-52 cells
were infected with negative control or RhoA miRNA-encoding adenovirus together with virus encoding wt or C16/20A myc-RhoA where indicated.
After 72 hours, total cell lysates were analyzed by western blot with a RhoA and B-actin antibody (loading control). Arrowhead indicates endogenous
RhoA; arrow indicates the slower migrating non-targeting, myc-RhoA constructs. (D) Activity assay of wt and C16/20A myc-RhoA constructs. REF-52
cells were infected with negative control or RhoA miRNA-encoding adenovirus together with virus encoding wt or C16/20A myc-RhoA. After
72 hours, cells were processed for RhoA activity assays (in the presence of serum) and analyzed by western blot with a myc antibody.
doi:10.1371/journal.pone.0008045.g003
RhoA Activation by ROS
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There is strong evidence that Rac1-derived ROS can lead to
oxidative inactivation of LMW-PTP, resulting in phosphorylation
and activation of p190RhoGAP and subsequent downregulation
of RhoA [12]. However, several studies have demonstrated that
exogenous peroxide induces effects consistent with activation of
RhoA [21,22,23,42]. Furthermore, Campbell et al. demonstrated
in vitro that ROS and RNS induce nucleotide displacement by
direct cysteine oxidation in the phosphoryl-binding site of RhoA.
If this oxidative event is reversed by reduction and GTP is present
in excess, nucleotide exchange (GTP binding) is favored and the
GTPase is activated [25]. Notably, this occurs in the absence of
GEFs. Our data support the mechanism described from their in
vitro observations. We show that the activation of RhoA by
peroxide is prevented by cysteine to alanine mutation of residues
Figure 4. C16/20A myc-RhoA is not activated by ROS but responds normally to other physiological stimuli. (A) REF-52 cells expressing
wt or C16/20A myc-RhoA were serum-starved and treated with the indicated concentrations of peroxide for 10 min. RhoA activity assays show that
the activity of wt myc-RhoA increases in response to peroxide, however, the C16/20A mutant is resistant to activation by peroxide. (B) ImageJ
software was used to quantify RhoA activation. Peroxide treated conditions are normalized to the corresponding untreated controls. Graph
represents the average +/2 SEM of 2 independent experiments. * p,0.05 compared to untreated control. (C) REF-52 cells in which endogenous RhoA
had been knocked down and re-expressing wt or C16/20A myc-RhoA were serum starved and treated with 1 U/mL thrombin to test their
responsiveness to GEF-mediated activation. RhoA activity assays show that both wt and C16/20A myc-RhoA are activated by thrombin at 1 and
5 min. (D) REF-52 cells in which endogenous RhoA had been knocked down and expressing wt or C16/20A myc-RhoA were treated with either GST
alone or GST-C3, as described in the methods. F-actin staining was detected with Texas-Red labeled phalloidin. C3 treatment results in a characteristic
dendritic morphology due to RhoA inactivation. Cells expressing either wt or C16/20A myc-RhoA develop the C3 phenotype.
doi:10.1371/journal.pone.0008045.g004
RhoA Activation by ROS
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16 and 20, although this mutant RhoA behaves normally in
response to GEF-mediated situations (thrombin stimulation).
It is interesting that Zuckerbraun et al. found that treatment of
cells with NO inhibits RhoA activity [43]. This apparent
discrepancy has been observed in cell-based studies of the Ras
GTPase, where both activation and inactivation of Ras have been
observed in the presence of exogenously supplied RNS [44].
Redox regulation of Ras and Rho GTPase activity is likely to be
dependent on a number of factors, including the type and level of
cellular oxidants, reduction potential, as well as differences in cell
lines resulting from variations in redox enzymes. If the oxidizing
agent is in excess, or in the absence of a cellular reducing agent
such as GSH, loss of GDP from RhoA can result in intramolecular
disulfide formation between C16 and C20, and this form of RhoA
is inactive, as it cannot bind nucleotide or interact with the GEF,
Vav2, in in vitro studies [25]. However, under conditions where
ROS/RNS are present at physiological levels and the reduction
potential is high, as is the case within the cell cytoplasm, GTPase
activation is expected, which is what we observe under our
experimental conditions.
The cell’s redox environment may also play a role in
distinguishing regulation of RhoA by ROS as opposed to classical
regulation by GEFs and GAPs. It is likely that ROS-mediated
pathways are occurring parallel to pathways involving classical
regulatory proteins. However, since ROS are typically very
reactive and have short half-lives, direct regulation of RhoA by
ROS is likely to be more spatially and temporally confined. This
confinement may be relaxed under conditions where the cell’s
redox environment is out of balance. Certainly, there are situations
where ROS are generated at increased levels physiologically and
pathologically. For example, the respiratory system is normally
exposed to greater concentrations of ROS than other tissues.
Pulmonary diseases associated with airway hyperresponsiveness,
such as asthma and COPD, have been shown to be associated with
increased ROS production [45]. ROS and RhoA activation have
been attributed to tracheal smooth muscle contractility, which is a
hallmark of these disease states [46,47]. We suspect that increased
levels of ROS under these conditions may directly activate RhoA
to drive smooth muscle contractility. Similarly, ischemia-reperfu-
sion injury is associated with increased ROS production, which
leads to pathology of the vascular system [48]. ROS-mediated
activation of RhoA has been demonstrated in vascular smooth
muscle [49]. Based on our results, we would predict that ROS may
activate RhoA signaling in smooth muscle and in the endothelium,
contributing to the massive increases in vascular permeability
associated with ischemia-reperfusion injury.
In addition, we suspect that other Rho family GTPases may be
directly regulated by ROS given the work of Campbell et al. [16].
For example, we show that Rac1 activity is regulated by peroxide
in epithelial and endothelial cells (Supporting Figure S2 and data
not shown). The regulation of Rac1 by ROS is particularly
interesting because of its involvement in ROS production, through
the NADPH oxidase complex [11], and its regulation by
superoxide dismutase-1 (SOD1) [50]. SOD1 modulates intracel-
lular ROS by converting superoxide to hydrogen peroxide. This
creates a potential feedback loop in which Rac1 activity generates
ROS which can regulate Rac1 activity through the redox-
dependent sensor SOD1. Overall, these effects may be cell type
specific, as the localization of a particular GTPase and baseline
levels of activity likely play an important role in how that GTPase
responds to ROS in terms of activity and phenotypic response.
We have shown that ROS can regulate RhoA activity in cells
via a mechanism involving critical cysteine residues present in a
redox-sensitive motif. This ROS-based mechanism of regulation
was previously suggested by biochemical studies in vitro [25]. Our
data support this occurring within cells and furthermore show that
in a cellular context oxidative modification of these residues is a
novel mechanism that can affect cytoskeletal dynamics.
Materials and Methods
Chemicals
T-butyl peroxide (peroxide) and N-acetyl cysteine (NAC) were
purchased from Sigma-Aldrich (St. Louis, MO). Antimycin A was
purchased from Axxora (San Diego, CA). Y-27632 was purchased
from Calbiochem/EMD Chemicals (Gibbstown, NJ). 6-carboxy-
29,79-dichlorodihydrofluorescein diacetate di(acetoxymethyl ester)
(DCFDA) was purchased from Molecular Probes (Eugene, OR).
Cell Lines
REF52 [51], Rat2 fibroblasts (CRL-1764, American Type
Culture Collection), and HeLa cells (CCL-2, American Type
Culture Collection) were grown in Dulbecco’s modified Eagle’s
medium (DMEM; Gibco) supplemented with 10% fetal bovine
serum (FBS; Sigma) and antibiotic-antimycotic solution (Gibco).
Knockdown of RhoA Using miRNA Adenovirus
miRNA adenoviral constructs were designed and engineered
using the BLOCK-iT TM Pol II miR RNAi expression vector system
(Invitrogen) according to the manufacturer’s protocol (Invitrogen).
Briefly, double-stranded oligonucleotides were designed using
Invitrogen’s RNAi Designer (www.invitrogen.com/rnai) to form
Figure 5. ROS induction of stress fibers is dependent on redox-
regulation of RhoA. Rat2 fibroblasts were infected with adenoviruses
to knockdown endogenous RhoA and re-express wt or C16/20A myc-
RhoA. These cells were seeded on fibronectin-coated coverslips, and
either left unstarved (DMEM +5% FBS), or serum-starved for 1 h
followed by treatment with DMEM alone, or 1 mM peroxide in DMEM for
15 min. Quantitation of stress fiber induction shows that compared
with the starved condition, peroxide treatment induces a statistically
significant increase in stress fibers in cells expressing wt myc-RhoA but
not in cells expressing redox-resistant C16/20A myc-RhoA. Graph
represents the mean of 3 independent experiments, with .300 cells
counted for each condition (error bars equal SD). * p,0.05; NS, not
significant. Actual percent cells with stress fibers for each condition is:
(unstarved) wt myc-RhoA 76.765.0%, C16/20A myc-RhoA 78.165.2%;
(starved) wt myc-RhoA 48.365.7%, C16/20A myc-RhoA 49.665.0%;
(peroxide) wt myc-RhoA 68.564.9%, C16/20A myc-RhoA 46.367.4%.
doi:10.1371/journal.pone.0008045.g005
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an engineered pre-miRNA sequence structure that targets a
conserved region in human, mouse, and rat RhoA:
59TGCTGAAGACTATGAGCAAGCATGTCGTTTTGGC-
CACTGACTGACGACATGCTCTCATAGTCTT39 (21 bp an-
tisense target sequence underlined). Synthesized oligonucleotides
were annealed and ligated into pcDNA 6.2-GW/EmGFP-miR.
The EmGFP-miRNA cassette was subsequently shuttled through
pDONR221(Invitrogen) by Gateway BP recombination and then
into pAd-CMV-Dest Gateway vector by LR recombination. Each
construct was sequence verified and virus was produced in 293A
packaging cell line with the ViraPower Adenoviral Expression
System (Invitrogen) using the manufacturer’s recommended
protocol.
Generation of Non-Targeting RhoA Constructs and
Adenoviral-Mediated Expression
In order to simultaneously knockdown endogenous RhoA while
allowing re-expression of RhoA mutants, non-targeting RhoA
constructs were designed. Human RhoA in pCMV-myc was used
as a template for site-directed mutagenesis (QuikChange II Site-
Directed Mutagenesis kit; Stratagene), wherein 5 silent DNA
basepair mutations were made within the miRNA targeting region
of RhoA. This non-targeted form of RhoA was then used as a
template for site-directed mutagenesis in order to generate cysteine
to alanine mutants at C16 and C20 (C16/20A myc-RhoA).
Adenovirus was generated using the Virapower adenoviral
expression system (Invitrogen) following the manufacturer’s
protocol as described above. For experiments, cells were infected
by overnight incubation with adenovirus-containing media
followed by addition of fresh DMEM/10% FBS for another 48 h.
Immunohistochemistry and Measurement of Stress Fiber
Induction
Rat2 cells treated with adenovirus to knockdown endogenous
RhoA while re-expressing either wt myc-RhoA or C16/20A myc-
RhoA were plated onto fibronectin-coated coverslips (15 ug/ml)
overnight, followed by serum-starvation for 1 h. Cells were treated
for 15 min with either serum-free or 1 mM peroxide-containing
DMEM, or 5% FBS-containing DMEM (positive control) before
fixing/permeabilizing in 3.7% paraformaldehyde, then 0.02%
Triton X-100. In some experiments, Rat2 cells were starved in the
presence of 5 mM Y27632. Texas Red phalloidin (Molecular
Probes) was used to stain F-actin. Immunofluorescence images
were taken through a 20x objective (Zeiss plan-Apochromat 20x/
0.8) with a Zeiss axiovert 200 M microscope equipped with a
Hamamatsu ORCA-ERAG digital camera and acquired using
Metamorph Workstation (Universal Imaging Corp.). To quantify
stress fiber induction, GFP-positive cells were scored by a blinded
observer for the presence or absence of stress fibers; the criteria
were: organized, thickened parallel actin bundles throughout the
majority of the cytoplasm. Results are plotted as a ‘‘stress fiber
induction index’’ which was obtained by normalizing each
treatment to the starved condition. Statistical significance was
determined by Student’s t-test of the average from 3 independent
experiments.
RhoA Activity Assays
RhoA activity assays [52] were performed as described
previously with minor modifications [53]. Cells were serum-
starved in DMEM for 2 hours prior to performing assays to lower
baseline RhoA activity and remove serum proteins which would
interfere with experimental conditions. Cells were washed with
ice-cold HEPES buffered saline (pH 7.4) and lysed in Buffer A
(50 mM Tris pH 7.6, 500 mM NaCl, 1% Triton X-100, 0.1%
SDS, 0.5% deoxycholate, 10 mM MgCl2, 100 mM orthovanadate
and protease inhibitors). Lysates were clarified by centrifugation
and equalized for total volume and protein concentration. After
incubation with glutathione S-transferase (GST)-Rho binding
domain (RBD) beads, washing three times with ice-cold Buffer B
(50 mM Tris pH 7.6, 150 mM NaCl, 1% Triton X-100, 0.5 mM
MgCl2, 100 mM orthovanadate, with protease inhibitors, the
bound fraction (active GTP-RhoA) was analyzed by SDS-PAGE.
Total RhoA levels were similarly analyzed using a reserved aliquot
of whole cell lysate. Active RhoA and total RhoA were analyzed
by Western blotting with an anti-RhoA antibody (monoclonal
antibody 26C4; Santa Cruz Biotechnology, Santa Cruz, CA). The
results were quantified using ImageJ software (NIH; Bethesda,
MD). The relative amount of active RhoA was determined by
taking the ratio of RhoA sedimented by GST-RBD beads (active
RhoA) divided by the amount of total RhoA in the whole cell
lysate. Statistical significance was determined using Student t-test
(one-tailed).
Rac1 Activity Assays
Rac1 activity assays [54,55] were performed as described
previously with minor modifications [56]. Cells were serum-
starved in DMEM for 1 hour prior to performing assays to lower
baseline Rac1 activity and to remove serum proteins which would
interfere with experimental treatments. Cells were washed with
ice-cold HEPES buffered saline (pH 7.4) and lysed in Buffer B
(50 mM Tris pH 7.6, 150 mM NaCl, 1% Triton X-100, 0.5 mM
MgCl2, 100 mM orthovanadate, and protease inhibitors). Lysates
were clarified by centrifugation and equalized for total volume and
protein concentration. After incubation with glutathione S-
transferase (GST)-PAK binding domain (PBD) beads and washing
three times with ice-cold Buffer B, the bound fraction (active GTP-
Rac1) was analyzed by SDS-PAGE. Total Rac1 levels were
similarly analyzed using a reserved aliquot of whole cell lysate.
Active Rac1 and total Rac1 were analyzed by Western blotting
with a monoclonal anti-Rac1 antibody clone 102 (BD Transduc-
tion Laboratories, San Jose, CA). The results were quantified using
ImageJ software (NIH; Bethesda, MD). The relative amount of
active Rac1 was determined by taking the ratio of Rac1
sedimented by GST-PBD beads (active Rac1) divided by the
amount of total Rac1 in the whole cell lysate. Statistical
significance was determined using Student t-test (one-tailed).
Measurement of ROS Generation
Formation of ROS was monitored by the conversion of non-
fluorescent 6-carboxy-29,79-dichlorodihydrofluorescein diacetate
di(acetoxymethyl ester) to fluorescent DCF. Cells were loaded
with 5 mM DCF in serum-free DMEM for 30 min at 37uC. After
loading, cells were washed twice with phosphate-buffered saline,
and incubated for an additional 20 min at 37uC to allow for dye
de-esterification. Cells were stimulated with antimycin A or
peroxide as described in the figure legends. Fluorescence was
determined using a fluorometer with an excitation of 485 and an
emission of 520.
C3 Treatment
GST-tagged recombinant proteins (either GST alone or GST-
C3) were isolated from BL-21 bacteria using the manufacturer’s
protocol for GST fusion proteins (Amersham Pharmacia Biotech).
Following adenovirus infection of REF-52 cells to knockdown
endogenous and re-express wt or C16/20A myc-RhoA as
described above, C3 toxin was introduced into these cells on
coverslipsusing Lipofectamine according to the protocol of
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Maddox et al. [57]. After 3 hours of C3 exposure, cells were fixed
and imaged as described above.
Supporting Information
Figure S1 Antimycin A induces ROS production. REF52
fibroblasts were loaded with 5 mM dichlorofluorescin diacetate
(DCFDA) for 30 min under serum free conditions, followed by
stimulation with 10 mM antimycin A (AA) for 5, 15 or 30 min.
Stimulation with 10 mM peroxide for 5 min was used as a positive
control.
Found at: doi:10.1371/journal.pone.0008045.s001 (0.04 MB TIF)
Figure S2 Peroxide activates Rac1 in HeLa Cells. HeLa cells
were serum-starved and treated with the indicated concentrations
of peroxide for 10 min. Rac1 activity assays show that peroxide
treatment results in activation of endogenous Rac1. A represen-
tative blot of active Rac1 sedimented by GST-PBD versus total
Rac1 from whole cell lysates is shown. ImageJ software was used to
quantify Rac1 activation. Graph represents the average +/2 SD
of 2 independent experiments. * p,.05 versus untreated control.
Found at: doi:10.1371/journal.pone.0008045.s002 (0.12 MB TIF)
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